JoergErmannMD
Rheumatology • Boston, MASpondyloarthropathy
Assistant Professor of Medicine, Harvard Medical School and Brigham and Women's Hospital
Dr. Ermann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
60 Fenwood Road
HBTM Room 6002P
Boston, MA 02115Phone+1 617-525-1227Fax+1 617-525-1010
Summary
- Dr. Joerg Ermann is a rheumatologist in Boston, MA and is affiliated with multiple hospitals in the area, including Brigham and Women's Hospital and Brigham and Women's Faulkner Hospital. He received his medical degree from University of Leipzig Faculty of Medicine and has been in practice 16 years. He also speaks multiple languages, including German. He specializes in spondyloarthritis.
Education & Training
Brigham and Women's HospitalFellowship, Rheumatology, 2006 - 2010
University of TennesseeResidency, Internal Medicine, 2004 - 2006
University of Leipzig Faculty of MedicineClass of 1994
Certifications & Licensure
MA State Medical License 2007 - 2024- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Fellow (FACR) American College of Rheumatology
Publications & Presentations
PubMed
- 74 citationsAllele-specific expression changes dynamically during T cell activation in HLA and other autoimmune loci.Maria Gutierrez-Arcelus, Yuriy Baglaenko, Jatin Arora, Susan K. Hannes, Yang Luo
Nature Genetics. 2020-02-17 - 891 citationsDonor-type CD4+CD25+ Regulatory T Cells Suppress Lethal Acute Graft-Versus-Host Disease after Allogeneic Bone Marrow TransplantationPetra Hoffmann, Joerg Ermann, Matthias Edinger, C. Garrison Fathman, Samuel Strober
The Journal of Experimental Medicine. 2002-08-05 - 1016 citationsCD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.Matthias Edinger, Petra Hoffmann, Joerg Ermann, Kathryn Drago, C. Garrison Fathman
Nature Medicine. 2003-08-17
Press Mentions
Lack of ‘Good Disease Model’ Inhibits Treatment Decision-Making in Axial SpondyloarthritisMay 7th, 2023- The Effects of IL-17A Inhibitors on the MicrobiotaFebruary 16th, 2021
Six Ways You Can Boost Your Immunity Right NowMarch 20th, 2020- Join now to see all
Professional Memberships
- Member
- Fellow
- Spondyloarthritis Research and Treatment NetworkVice Chair
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
